Schwab D M, Katus H A, Raake P W
Klinik für Kardiologie, Angiologie und Pneumologie, Innere Medizin III, Medizinische Klinik, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 410, 69120, Heidelberg, Deutschland.
Internist (Berl). 2019 Mar;60(3):304-308. doi: 10.1007/s00108-019-0559-x.
This article presents the case of a 22-year-old male patient with cardiomyopathy associated with a long history of methamphetamine abuse. Echocardiography revealed a dilated cardiomyopathy with highly reduced systolic pump function and severe mitral valve regurgitation. Inotropic treatment and MitraClip® (Abbott Vascular, Santa Clara, CA, USA) implantation resulted in enhancement of hemodynamics. The rising prevalence of methamphetamine abuse should give reason to raise awareness for the diagnostic work-up and patient history particularly in cases of unexplained cardiomyopathy in young patients.
本文介绍了一名22岁男性患者的病例，该患者患有与长期滥用甲基苯丙胺相关的心肌病。超声心动图显示为扩张型心肌病，收缩泵功能严重降低，伴有严重二尖瓣反流。使用正性肌力药物治疗并植入MitraClip®（美国雅培血管公司，加利福尼亚州圣克拉拉）后，血流动力学得到改善。甲基苯丙胺滥用的患病率不断上升，这应该促使人们提高对诊断检查和患者病史的认识，尤其是在年轻患者出现不明原因心肌病的情况下。
